Ocular Surface Toxicity of Antibody–Drug Conjugates: Pathogenesis, Diagnosis, Grading, and Treatment of Ocular Adverse Effects

作者
Winston Chamberlain,Clara C. Chan,Amy Lin,Karolinna M. Rocha,Beeran Meghpara,Sumitra Khandewal,Michelle K. Rhee,Zachary J. Zavodni,Sumit Garg,Marjan Farid,Naveen K. Rao
出处
期刊:Cornea [Lippincott Williams & Wilkins]
卷期号:45 (11): 1339-1350
标识
DOI:10.1097/ico.0000000000004122
摘要

PURPOSE: The American Society of Cornea and Refractive Surgery Cornea Committee convened to create a brief review of the literature and expert experience of antibody-drug conjugates (ADCs) and their impact on ocular surface health. METHODS: Peer-reviewed publications from 2003 to 2025 were evaluated. The information along with authors clinical experience was used to create a white paper on the current aspects ADC therapy that is relevant to the ocular surface health. RESULTS: There are currently 14 Food and Drug Administration-approved ADCs. By most recent estimates in the literature, there are more than 200 ADCs currently in development, and a significant proportion of them are associated with keratopathy that has unique ocular surface manifestations. Features of ADC-induced keratopathy include corneal pseudocysts, superficial punctate keratitis, refractive shifts, and conjunctival hyperemia. More severe adverse events such as conjunctival hemorrhage, conjunctival scarring, and corneal ulcers are rare. These findings correlate with change in visual acuity and visual quality. Eye care providers need guidance to recognize, understand, and communicate critical features of vision health with referring oncologists. CONCLUSIONS: Given the anticipated surge in oncology patients on ADCs, there is a need for dissemination of information on ocular surface concerns. This review covers key aspects ADC toxicity mechanisms and pathological features on the ocular surface health including strategies to diagnose, grade, and treat disease. It also provides expectations on the eye care provider's role in communication with referring oncologists.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
TPolymer完成签到,获得积分10
2秒前
脑洞疼的应助被扶竹苏春采纳,获得10
3秒前
化学废材完成签到,获得积分10
4秒前
CodeCraft的应助被hyska采纳,获得10
5秒前
含蓄书桃发布了新的文献求助10
6秒前
6秒前
7秒前
8秒前
健康的魔镜完成签到 ,获得积分10
10秒前
华无剑的应助被DW采纳,获得10
10秒前
11秒前
小乐乐完成签到 ,获得积分10
11秒前
斯文败类的应助被淡淡青枫采纳,获得10
13秒前
14秒前
山海不远发布了新的文献求助10
15秒前
uniphoton完成签到,获得积分10
16秒前
fatal发布了新的文献求助10
18秒前
111发布了新的文献求助10
18秒前
粥粥粥完成签到 ,获得积分10
19秒前
ding的应助被木木采纳,获得10
20秒前
叶上初阳完成签到,获得积分0
20秒前
干咸鱼叔叔完成签到,获得积分10
21秒前
GoGoGo完成签到,获得积分10
22秒前
hitech的应助被fatal采纳,获得10
24秒前
科研通AI6.2的应助被山海不远采纳,获得30
25秒前
含蓄书桃完成签到 ,获得积分10
25秒前
spark发布了新的文献求助10
26秒前
Crazy鑫完成签到,获得积分10
28秒前
29秒前
30秒前
快乐鼠完成签到,获得积分10
32秒前
33秒前
33秒前
WLLLR发布了新的文献求助10
33秒前
桓某人发布了新的文献求助10
34秒前
36秒前
choin6688_完成签到 ,获得积分10
37秒前
lyj发布了新的文献求助10
37秒前
眼睛大泥猴桃完成签到,获得积分10
37秒前
隐形曼青的应助被乐乐采纳,获得10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196